BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7144086)

  • 1. [Opportunistic microorganisms: the causative agents of hospital infections].
    Kochemasova ZN; Dratvin SA; Matveeva EA; Ozherel'eva NG
    Klin Med (Mosk); 1982; 60(8):72-6. PubMed ID: 7144086
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nosocomial infections yesterday and today. II. Preventive trends in infections with opportunistic microorganisms].
    Teodorovici G; Ivan A; Groll M
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(4):579-83. PubMed ID: 550246
    [No Abstract]   [Full Text] [Related]  

  • 3. New guidelines for fighting multidrug-resistant organisms.
    Walker BW
    Nursing; 2007 May; 37(5):20. PubMed ID: 17468605
    [No Abstract]   [Full Text] [Related]  

  • 4. [Selective decontamination of digestive tract. A way to control intensive care infections].
    Blomqvist H; Burman L; Ekwall E
    Lakartidningen; 2004 Mar; 101(11):966-7. PubMed ID: 15055116
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellphones as reservoirs of nosocomial pathogens.
    Jayalakshmi J; Appalaraju B; Usha S
    J Assoc Physicians India; 2008 May; 56():388-9. PubMed ID: 18700649
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibiotic strategies in an intensive care service].
    Georges B
    Presse Med; 2000 Jan; 29(1):61-3. PubMed ID: 10682061
    [No Abstract]   [Full Text] [Related]  

  • 7. [Management of multiresistant bacteria].
    Ramé A
    Rev Infirm; 2006 May; (121):32-3. PubMed ID: 16792047
    [No Abstract]   [Full Text] [Related]  

  • 8. [Can selective decontamination of the digestive tract as a routine procedure on intensive care units be recommended?].
    Späth G
    Zentralbl Chir; 1995; 120(6):417-25. PubMed ID: 7639028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of bacterial pathogens in surgical wound infections.
    Oni AA; Bakare RA; Okesola AO; Ogunlowo HA; Ewete AF
    Afr J Med Med Sci; 1997; 26(3-4):139-40. PubMed ID: 10456156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and efficacy of infection-control interventions to reduce the number of nosocomial infections and drug-resistant microorganisms in developing countries: what else do we need?
    Apisarnthanarak A; Fraser VJ
    Clin Infect Dis; 2009 Jan; 48(1):22-4. PubMed ID: 19067618
    [No Abstract]   [Full Text] [Related]  

  • 11. [Disinfection of the environment and patients on intensive care units].
    Daschner F; Dettenkofer M
    Zentralbl Chir; 1996; 121 Suppl():35-6. PubMed ID: 8967232
    [No Abstract]   [Full Text] [Related]  

  • 12. [The current epidemics of nosocomial infection in the field of surgery].
    Hirose T
    Hokkaido Igaku Zasshi; 1994 Mar; 69(2):166-9. PubMed ID: 8157241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new threat to antibiotic resistance: why we need a health policy.
    Young L; Sattler B
    Am Nurse; 2002; 34(3):17. PubMed ID: 12077969
    [No Abstract]   [Full Text] [Related]  

  • 14. [Health care related infections caused by multiresistant microorganisms--how to beat them].
    Suljagić V
    Vojnosanit Pregl; 2008 May; 65(5):341-2. PubMed ID: 18630125
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hygiene Series--16: Prevention of nosocomial urinary tract infections: carelessness is dangerous].
    Loczenski B
    Pflege Z; 2006 Oct; 59(10):618-21. PubMed ID: 17069407
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bacterias resist...].
    Fuchs D
    Soins; 1997 Nov; (620):5. PubMed ID: 9479196
    [No Abstract]   [Full Text] [Related]  

  • 17. [Environmental health on the neonatal unit: what is the role of routine surface disinfection?].
    Panknin HT
    Kinderkrankenschwester; 2014 Sep; 33(9):343-4. PubMed ID: 25295374
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective digestive tract decontamination--will it prevent infection with multidrug-resistant gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are endemic?
    Bonten MJ
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S70-4. PubMed ID: 16894518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two new forms of Augmentin and Ciblor, frequently used in the fight against cross infections].
    Oudart N
    Rev Infirm; 1999 Apr; (48):55-6. PubMed ID: 10532085
    [No Abstract]   [Full Text] [Related]  

  • 20. [Isolation precautions. Multidrug resistant bacteria].
    Fuchs D
    Soins; 1997 Nov; (620):22-3. PubMed ID: 9479201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.